The Cancer Letter

Inside information on cancer research and drug development

Vol.
33
No.
2
February 26, 2010Feb 26, 2010
Free
DOWNLOAD THE PDF

Breast Cancer Survivors Who Take Aspirin Have 50% Reduced Risk Of Metastasis

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

Racial Disparities Persist In Diagnosis Of Advanced Breast Cancer, Colon Cancer

Breast Cancer Rates Decline Most for Affluent White Women

Low Prevalence Of Tamoxifen Use For Cancer Prevention

Symptoms Don’t Help Detect Early-Stage Ovarian Cancer

Two-Week Break Balances RT Palliation, Side Effects

NCI Cooperative Group Clinical Trials Approved

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account